Skip to main content
. 2024 Sep 16;24:981. doi: 10.1186/s12879-024-09880-2

Table 1.

Characteristics of patients whose archived samples were used in this study

Characteristics Total N (%) SpeeDx, + n (%) p-valuee TIB Molbiol, +ve n (%) p-valuee
a Sex
Male 393(38.9) 19(4.8) 0.058 16(4.1) 0.141
Female 617(61.1) 16(2.6) 15(2.4)
b Age (years)
18–24 301(29.9) 12(4.0) 0.295 12(4.0) 0.349
25–31 413(41.0) 12(2.9) 10(2.4)
32–38 191(19.0) 10(5.2) 8(4.2)
39–45 70(7.0) 0(0.0) 0(0.0)
Above 46 32(3.2) 1(3.1) 1(3.1)
c Education
No schooling 36(3.6) 1(2.8) 0.779 1(2.8) 0.986
Basic 185(18.4) 8(4.3) 6(3.2)
Secondary and above 782(78.0) 26(3.3) 24(3.1)
Symptoms
Dysuria and/or urethral discharge 961(94.7) 33(3.4) 0.916 29(3.0) 0.776
dOther symptoms 54(5.3) 2(3.7) 2(3.7)
Gonorrhea infection
Positive 246(24.2) 10(4.1) 0.542 9(3.7) 0.527
Negative 769(75.8) 25(3.3) 22(2.9)
Chlamydia infection
Positive 100(9.9) 3(3.0) 0.796 3(3.0) 0.974
Negative 915(90.1) 32(3.5) 28(3.1)

Gonorrhea/Chlamydia

Coinfection

Yes 1,310(97.1) 1(3.1) 0.919 1(3.1) 0.981
No 39(2.9) 34(3.5) 30(3.1)
Total 1015 35(3.4) 31(3.1)

a5 patients’ information on sex was missing

b8 patients’ information on age was missing

c12 patients’ information on education was missing

ditching, abdominal pain, pain when having sex, foul smell/odor from urine, bleeding from penis or vagina

ep-values were obtained using a Chi-square test

+ve: positive